Jennifer Ancona
Physician Assistant · Port Jefferson, NYNPI 1134219124
Payments from drug & device makers
Across 170 payments — averaging $25.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Regeneron Healthcare Solutions, Inc.$893
- AstraZeneca$851
- Sanofi$286
- Amgen$258
- Optinose US, Inc.$215
- plus $870 from 16 others
What the payments were for
- Consulting fees$61514%
- Food & beverage$3,77486%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 54 | $1,016 |
| Regeneron Healthcare Solutions, Inc. | 12 | $893 |
| AstraZeneca | 32 | $851 |
| Sanofi | 11 | $286 |
| Amgen | 8 | $258 |
| Optinose US, Inc. | 10 | $215 |
| Biocryst US Sales Co., LLC | 8 | $152 |
| Kaleo, Inc. | 5 | $102 |
| Incyte Corporation | 5 | $88 |
| Pfizer | 3 | $67 |
| Merck | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 3 | $61 |
| Blueprint Medicines Corporation | 2 | $55 |
| Novartis | 2 | $54 |
| AbbVie | 2 | $45 |
| Octapharma USA, Inc. | 2 | $41 |
| Hikma Pharmaceuticals USA | 2 | $31 |
| LEO Pharma Inc. | 1 | $30 |
| Eyevance Pharmaceuticals LLC | 2 | $26 |
| Grifols USA, LLC | 1 | $20 |
| Genentech USA, Inc. | 1 | $20 |
| CSL Behring | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,389 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 25 | $91,314 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $15,721 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 17 | $2,014 |
| Azelastine Hcl | 28 | $949 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $886 |
| Montelukast Sodium | 27 | $395 |
| Levocetirizine Dihydrochloride | 30 | $326 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $1,016 | $15,72121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Port Jefferson
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
- Lawrence HermanHolbrook$315K
- Kaitlyn NelsonBrooklyn$289K
- Sari KatzGarden City$271K
- Julius NwosuBronx$256K
- Cameron KiserNew York$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.